Impact Factor
3.44
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.68
1,171 total citations
h5-index
29
h5 depth signal
Cited share
72.8%
330 of 453
Total citations
1,171
Citation footprint
Metric signal
2.05
External metric anchor
Self-citation
1.2%
14 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
329
China
312
Japan
184
Iran
181
India
108
Citing Fields of Research
Oncology
628
Breast Cancer
209
Immunology
181
Cancer & Development
179
Hematology
156
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,709
Articles tracked across the journal lifetime
Indexed publication set
453
330 cited publications
Last 12 months
321
26.8 publications/month
Open access share
100.0%
321 OA publications in the last year
Leading citing country
United States
329 citing publications
Leading citing field
Oncology
628 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v1n1, June 2018-
v1n1, June 2018-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Breast Cancer
Immunology
Lung Cancer
Hematology
Liver & Colon Cancer
Broad Categories
Neoplasms
Hematology
Liver & Colon Cancer
Breast Cancer
Noncoding RNA
Immunology
Digestive Disorders
Musculoskeletal & Nerve Cancer
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/cnr2.70721
Open DOI
Behavior Change Interventions to Promote Healthy Lifestyles Among Adolescent and Young Adult Childhood Cancer Survivors: A Scoping Review
Background: Adolescent and young adult childhood cancer survivors (AYA‐CCS) face elevated risks of chronic health conditions and premature mortality further exacerbated by poor lifestyle behaviors including physical inactivity, poor nutr...
02
03
DOI 10.1002/cnr2.70719
Open DOI
GPR68 Inhibition Induces Ferroptosis in Atypical Teratoid Rhabdoid Tumors
Background: Atypical teratoid/rhabdoid tumors (ATRTs) are aggressive pediatric CNS malignancies with < 30% 5‐year survival despite multimodal therapy. No prior studies have explored ferroptosis induction in ATRT. Aims: To determine wheth...
04
DOI 10.1002/cnr2.70722
Open DOI
Survival Status and Predictors of Mortality Among Women With Breast Cancer in Southern Ethiopia: A Retrospective Cohort Study
Introduction: Breast cancer continues to be a leading cause of morbidity and mortality worldwide, with an especially severe impact in low‐resource settings. In such contexts, delayed diagnosis, limited diagnostic capacity, and inadequate...
05
DOI 10.1002/cnr2.70664
Open DOI
Periprocedural Wound Complication Risks in Cancer Pain Patients Following Targeted Cancer Therapy: A Retrospective Analysis
Background: In light of the increasing use of advanced operative procedures for cancer pain, it is crucial for pain physicians to understand the unique potential risks associated with multimodal cancer treatments. Aims: We aimed to chara...
06
DOI 10.1002/cnr2.70709
Open DOI
Retrospective Analysis of Zolbetuximab‐Associated Hypoalbuminemia in Claudin 18.2‐Positive Advanced Gastric Cancer
Background: Hypoalbuminemia has been recognized as a characteristic adverse event associated with zolbetuximab plus chemotherapy in the treatment of claudin 18.2‐positive advanced gastric cancer. However, its incidence, clinical predicto...
07
DOI 10.1002/cnr2.70700
Open DOI
Patient and Caregiver Reported Barriers to Cancer Clinical Trial Participation: A Scoping Review
Background: The development of cancer treatments relies on patient participation in clinical trials, yet poor recruitment and retention hinder evidence generation. There exists an urgent need for trial designs that address patient‐identi...
08
DOI 10.1002/cnr2.70704
Open DOI
Peripheral Lymphocyte Subsets Predict Efficacy and Overall Survival in Gastric Cancer Patients Receiving Preoperative Chemotherapy: A Retrospective Cohort Study
Background: Pathologic complete response (pCR), which reflects the local immune status and preoperative chemotherapy efficacy, has garnered significant attention in gastric cancer research. However, the predictive value of peripheral lym...
09
DOI 10.1002/cnr2.70632
Open DOI
The Prognostic Role of Vimentin Expression in Triple‐Negative Breast Cancer: A Retrospective Cohort Study
Introduction: Triple‐negative breast cancer (TNBC) is a subtype of breast cancer with the poorest prognosis and aggressive biological behavior. In Indonesia, approximately 15%–25% of breast cancer cases fall into the TNBC category. One o...
10
DOI 10.1002/cnr2.70720
Open DOI
Clinical Markers of Vulnerability for Bleeding in Men With Prostate Cancer and Antithrombotic Treatment
Purpose: Men with prostate cancer have a high risk for bleeding when treated with antithrombotics. The aim of this study was to investigate clinical markers for vulnerability for bleeding in these men the last year of life. Methods: This...
Bibliographical & Catalog Notes
Volume 1 complete with four issues.
Some volumes contain special issues.